MedTrace Logo

Longer-Acting PrEP in Transgender and Gender Diverse Texans

NCT05044286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 565

Last updated 2023-12-28

No results posted yet for this study

Summary

The long-term goal of this project is to increase uptake and adherence of LA-PrEP in TGD populations in Texas. The central hypothesis is that strategies to increase uptake of LA- PrEP that are patient centered and understand the needs of TGD people will improve uptake and adherence. The objective of this observational study is to investigate barriers, facilitators, and preferences regarding willingness and intention to use LA-PrEP in TGD populations in Texas. Data from this study will support future research on patient centered strategies for uptake and adherence of LA-PrEP in TGD populations.

Conditions

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Texas Health Institute

    collaborator UNKNOWN

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Transgender Education Network of Texas

    collaborator UNKNOWN

  • University of Texas at Austin

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-01-17
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044286 on ClinicalTrials.gov